CASR and Alzheimer disease: During the initial phases of disease progression in AD-model animals, the decline of GABABR1s’ availability, which concurs with CaSR’s overexpression, induced a neuronal hyperactivity in hippocampal and cerebrocortical circuits, whose upshot was functional impairment (Busche and Konnerth 2015).